AVR 1.18% $15.12 anteris technologies ltd

Eureka report, page-11

  1. 13,928 Posts.
    lightbulb Created with Sketch. 125
    Listened to the interview again. A third VIV patient was recently approved by Health Canada. Missed that little snippet the first time round.

 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.